REVA Medical Competitors and Similar CompaniesClear all

REVA Medical's competitors and similar companies include TissueGen, ConvaTec, Inspiration Healthcare Group and IHSS.

	REVA Medical REVA Medical is dedicated to developing minimally invasive medical devices.	TissueGen TissueGen is a company that specializes in polymer-based drug delivery systems.	ConvaTec ConvaTec Group is a medical products and technologies company focused on solutions for the management of chronic conditions.	Inspiration Healthcare Group Inspiration Healthcare offers an innovative range of critical care products aimed at improving outcomes for patients.	IHSS IHSS is a provider of sterile services for reusable surgical instruments.
Founding Date	Founding Date 1998	Founding Date 2000	Founding Date 1978	Founding Date 2003	Founding Date 2009
Type	Type Private	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare medical devices surgical solutions	Tags Healthcare bioengineering biotech pharma polymers	Tags Healthcare medical devices surgical solutions	Tags Healthcare medical devices surgical solutions	Tags Healthcare medical devices surgical solutions
Locations	Locations San Diego, US HQ	Locations Dallas, US HQ	Locations Reading, GB HQ Buenos Aires, AR Melbourne, AU Mulgrave, AU Wien, AT Fanipaĺ, BY Braine L'alleud, BE see more	Locations West Sussex, GB HQ Earl Shilton, GB Newtownards, GB	Locations London, GB HQ Aylesford, GB Aylesham, GB Ruislip, GB
Employees	Employees 51	Employees 11	Employees 10,489	Employees 224	Employees 6164% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 6 b	Valuation ($) 19.2 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $45k (FY, 2017)	Revenue (est.) N/A	Revenue (est.) $2.4b (FY, 2025)	Revenue (est.) £38.3m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $42k (FY, 2017)	Cost of goods N/A	Cost of goods $844m (FY, 2025)	Cost of goods £9.4m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $3k (FY, 2017)	Gross profit N/A	Gross profit $1.6b (FY, 2025)	Gross profit £28.9m (FY, 2025)	Gross profit N/A
Net income	Net income $7.1m (FY, 2017)	Net income N/A	Net income $175m (FY, 2025)	Net income (£15m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 59.6m	Total funding raised N/A	Total funding raised $ 1.2b	Total funding raised N/A	Total funding raised N/A